GlassScriptPhysician profile
Brad S Efaw
NPI 1841275229
$4,523.03
in general payments reported to CMS, 2019-2025
31 companies · $1,606 in 2025
The $1,606 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $76.13 · 2021: $119 · 2022: $574 · 2023: $588 · 2024: $1,450 · 2025: $1,606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,643.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $744.29 | 2021-2025 | Vraylar, Ubrelvy |
| Novo Nordisk INC | $553.86 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $541.32 | 2020-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $418.36 | 2020-2025 | Jardiance, Mounjaro, Zepbound |
| Pfizer INC. | $248.83 | 2023-2025 | |
| Astellas Pharma US INC | $190.46 | 2023-2025 | Veozah |
| Janssen Pharmaceuticals, INC | $176.47 | 2023-2024 | Spravato |
| Amgen INC. | $162.97 | 2019-2025 | Repatha, Otezla, Otezla |
| Phathom Pharmaceuticals, INC. | $144.13 | 2024-2025 | Voquezna |
| Glaxosmithkline, LLC. | $137.42 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.40 | 2022-2025 | Jardiance, Ofev |
| Exact Sciences Corporation | $129.51 | 2023-2025 | Cologuard Collection Kit |
| Boston Scientific Corporation | $107.58 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $107.40 | 2025 | Caplyta |
| E.R. Squibb & Sons, L.L.C. | $102.35 | 2024-2025 | Camzyos, Eliquis |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $80.98 | 2024-2025 | Rexulti |
| Dexcom, INC. | $69.81 | 2022-2024 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $59.43 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.43 | 2022-2023 | Cycloset |
| Abbott Laboratories | $51.31 | 2022-2024 | Freestyle Libre 3 |
| Sanofi Pasteur INC. | $49.54 | 2023 | |
| Cranial Technologies, INC | $48.98 | 2025 | Doc Band |
| Xeris Pharmaceuticals, INC. | $37.35 | 2024-2025 | Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $33.57 | 2022-2024 | |
| Azurity Pharmaceuticals, INC. | $30.86 | 2024-2025 | |
| Axsome Therapeutics, INC. | $23.18 | 2024 | Auvelity |
| Esperion Therapeutics, INC. | $22.00 | 2021 | |
| Optinose US, INC. | $19.02 | 2025 | |
| Novartis Pharmaceuticals Corporation | $17.18 | 2023 | |
| Corcept Therapeutics | $16.75 | 2025 | Korlym |
| Amneal Pharmaceuticals LLC | $14.29 | 2023 | Unithroid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Efaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.